Meperidine Drugs Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 4.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Meperidine Drugs Market Analysis
The global meperidine drugs market size is expected to grow at a CAGR of 4.1% over the forecast period. Increasing prevalence of diseases that cause chronic pain, such as cancer, periodontal disorders, postsurgical pain, lower back pain, fibromyalgia, and arthritis, is driving the market. As per the study of 'Postoperative Pain Control', around 75 percent of patients who undergo surgery experience acute postoperative pain, which is often medium-high in severity which further bolster the overall growth.
A key trend observed in the market is a significant rise in geriatric population, on the heels of increasing demand for pain relief solutions. This trend is likely to continue positively influencing the demand for meperidine drugs. Growing demand of meperidine drugs is driven by the cost efficiency of OTC analgesics drugs, technological advancement in the field of drug delivery systems, and increasing awareness amongst patients.
The wide range of application posses high probability to provide lucrative growth opportunities to meperidine drugs market. Some of the applications includes headache, muscle strain, bruising, or arthritis for recovering the modest pain. However, meperidine abuse, dependency and side effects of drugs may restrict the market.
Meperidine Drugs Market Trends
This section covers the major market trends shaping the Meperidine Drugs Market according to our research experts:
The Anesthesia Segment is Expected to Show the Highest CAGR And is Expected to Continue the Same during the Forecast Period
- Anesthesia are expected to grow at a lucrative CAGR during the forecast period. There has been an increase in number of surgical procedures performed across the globe, including dental procedures, cosmetic surgeries, and plastic surgeries. This is a major factor driving the market for anesthetic segment. This growth is supplemented by increasing healthcare expenditure in developing countries such as India, China, and Brazil, where the number of surgeries performed has been on a steady rise.
- The high growth potential attained is a consequence of aging population with chronic diseases. The positive patient outcomes can be attributed to significant improvements in post-operative pain relief.
- In addition, the pain relief segment is anticipated to grow rapidly in the market mainly due to high usage of the drug in pain management therapies. However, product usage for pain is expected to decline over the forecast period owing to implementation of new regulatory framework. A new guideline has been designed by the CDC for Prescribing meperidine for Chronic Pain.
The North America Dominates the Market and is Expected to Continue the Same during the Forecast Period
North America held the largest share in the market owing to the significant number of surgical procedures performed in the U.S. Increasing incidence of pain and pain-related disorders coupled with the escalating prevalence of chronic disorders are among factors driving the market in this region. This has been adding to healthcare expenditures of the nations in the region. Incremental rise in the number of patients and increasing product cognizance & adoption has also been accelerating market growth in the region.
The Asia-Pacific is expected to witness the fastest growth over the forecast period. The growth is attributed to increasing volume of dental and cosmetic surgeries, advancements in surgical procedures, and growing use of meperidine in post-operative pain management. Moreover, expanding geriatric population, is anticipated to drive the number of surgical procedures performed in the region, thereby promising the growth over the forecast period.
Meperidine Drugs Industry Overview
The meperidine drugs market is moderately competitive and consists of selective number of major players. Investment for the development of effective & long-acting products with lesser adverse effects and improving geographic penetration through partnerships and collaboration are the key strategies adopted by the companies to increase their market share.
The major players include companies such Sanofi Aventis, Mallinckrodt Pharmaceuticals, Pfizer Inc., Epic Pharma, Novartis (Sandoz Canada Inc.), Sun Pharmaceutical, VINTAGE PHARMS and Teva Pharmaceutical.
Meperidine Drugs Market Leaders
Sanofi Aventis
Mallinckrodt Pharmaceuticals
Pfizer Inc
Novartis (Sandoz Canada Inc.)
Epic Pharma
*Disclaimer: Major Players sorted in no particular order
Meperidine Drugs Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Assumptions
-
1.2 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Expanding Application of Meperidine in Various Therapeutic Conditions
-
4.2.2 Rising Prevalnce of Chronic Pain & Infectious Disease
-
-
4.3 Market Restraints
-
4.3.1 Meperidine Abuse and Dependency
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Route Of Administration
-
5.1.1 Oral
-
5.1.2 Parenteral
-
-
5.2 By Application
-
5.2.1 Pain Relief
-
5.2.2 Anesthesia
-
5.2.3 Cough Suppression
-
5.2.4 Diarrhea Suppression
-
5.2.5 De-addiction
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia-Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Rest of the World
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Epic Pharma
-
6.1.2 Mallinckrodt Pharmaceuticals
-
6.1.3 Pfizer Inc.
-
6.1.4 Novartis (Sandoz Canada Inc.)
-
6.1.5 Sanofi Aventis
-
6.1.6 Sun Pharmaceutical
-
6.1.7 Teva Pharmaceutical
-
6.1.8 Vintage Pharms
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Meperidine Drugs Industry Segmentation
As per the scope of the report, meperidine is a narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration. Meperidine drug market is segmented by route of administration, application and geography.
| By Route Of Administration | |
| Oral | |
| Parenteral |
| By Application | |
| Pain Relief | |
| Anesthesia | |
| Cough Suppression | |
| Diarrhea Suppression | |
| De-addiction |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| Rest of the World |
Meperidine Drugs Market Research FAQs
What is the current Meperidine Drugs Market size?
The Meperidine Drugs Market is projected to register a CAGR of 4.10% during the forecast period (2024-2029)
Who are the key players in Meperidine Drugs Market?
Sanofi Aventis , Mallinckrodt Pharmaceuticals, Pfizer Inc, Novartis (Sandoz Canada Inc.) and Epic Pharma are the major companies operating in the Meperidine Drugs Market.
Which is the fastest growing region in Meperidine Drugs Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Meperidine Drugs Market?
In 2024, the North America accounts for the largest market share in Meperidine Drugs Market.
What years does this Meperidine Drugs Market cover?
The report covers the Meperidine Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Meperidine Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Meperidine Drugs Industry Report
Statistics for the 2024 Meperidine Drugs market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Meperidine Drugs analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
